ArticleCancers2023

Real World Experience of Second-Line Treatment Strategies after Palbociclib and Letrozole: Overall Survival in Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.

Ji-Yeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.